Results 141 to 150 of about 7,789 (204)

Successful treatment of poison ivy dermatitis with upadacitinib. [PDF]

JAAD Case Rep
Tai H, Tang A, Levine J, Talia J, Ungar B.   +4 more
europepmc   +1 more source

A 17-Year-Old Male Adolescent With Refractory Crohn's Disease Managed With Upadacitinib and Risankizumab Combination Therapy: A Case Report and Review of Current Evidence. [PDF]

Am J Case Rep
Alhashemi M, Shehab M.
europepmc   +1 more source

Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years [PDF]

Christina Charles‐Schoeman, Jon T. Giles, Nancy E. Lane, Ernest Choy, Daniel E. Fürst, Jiří Vencovský, Anthony G. Wilson, Gerd R Burmester, Derek Coombs, S. Penn, Nasser Khan, Jillian B. Yee, Kassim Rahawi, Iain B. McInnes   +13 more
openalex   +1 more source

Upadacitinib for recalcitrant extraintestinal Crohn disease. [PDF]

JAAD Case Rep
Seward AH, Callen JP.
europepmc   +1 more source

Real-World Experience with Upadacitinib in Patients with Atopic Dermatitis and Hidradenitis Suppurativa: A Dual-Center Case Series. [PDF]

Clin Cosmet Investig Dermatol
Martora F, Megna M, Molinelli E, Gambini D, Simonetti O, Cimmino M, Napolitano M.   +6 more
europepmc   +1 more source

Prospective Bi-Centric Real-World Outcomes of Upadacitinib in Biologic-Experienced Patients with Crohn's Disease. [PDF]

Diseases
Lüke J, Zippel C, Tepasse PR, Lenze F, Strauss M, Bokemeyer A, Buskermolen J, Schomacher T, Fischer J, Trebicka J, Vollenberg R.   +10 more
europepmc   +1 more source

Upadacitinib Maintenance Therapy in Pediatric Ulcerative Colitis: 52-Week Multicenter Study From the Porto Group of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition

Anat Yerushalmy-Feler, Elizabeth A. Spencer, Marla C. Dubinsky, David L. Suskind, Katarína Mitrová, Ondřej Hradský, Máire A. Conrad, Judith R. Kelsen, Malgorzata Sladek, Pai-Jui Yeh, Christos Tzivinikos, Paul Henderson, Magdalena Wlazlo, Lukas Hackl, Dror S. Shouval, Natalia Mouratidou, Matteo Bramuzzo, Darja Urlep, Christine Olbjørn, Giulia Mancuso, Anna-Maria Schneider, Gemma Pujol-Muncunill, Dotan Yogev, Ben Kang, Marco Gasparetto, Christine Rungø, Claudio Romano, Massimo Martinelli, Kaija-Leena Kolho, Iva Hojsak, Lorenzo Norsa, Firas Rinawi, Naire Sansotta, Ramit Magen‐Rimon, Maya Granot, Luca Scarallo, Eunice Trindade, Marta Velasco Rodríguez-Belvís, Dan Turner, Shlomi COHEN   +39 more
openalex   +2 more sources

Real-World Effectiveness and Safety of Upadacitinib and Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Study [PDF]

Luciano Ibba, Costanza Falcidia, S. Di Giulio, Matteo Bianco, Mario Valenti, Paola Facheris, Alessandra Narcisi, Antonio Costanzo, Luigi Gargiulo   +8 more
openalex   +1 more source

Upadacitinib for Immune Checkpoint Inhibitor-Related Dermatitis: A Nonrandomized Clinical Trial.

JAMA Oncol
Chen C, Liang X, Peng Z, Zou Y, He H, Zhang X, He Y, Wu S.   +7 more
europepmc   +1 more source

Xanthogranuloma disseminatum: Successfully treated with statins followed by upadacitinib. [PDF]

JAAD Case Rep
Okundia F, Bouchelkia I, Shakhashiro M, Doan HQ, Tyring S.   +4 more
europepmc   +1 more source